New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2014
07:01 EDTFLDMFluidigm price target raised to $47 from $28 at Cantor
Cantor increased its price target on Fluidigm after the company acquired privately held DVS Sciences. The firm thinks the deal further strengthens and diversifies Fluidigm's already highly capabilities in single-cell genomics, and leaves the company better positioned to accelerate market expansion for single-cell analysis. The firm keeps a Buy rating on the stock.
News For FLDM From The Last 14 Days
Check below for free stories on FLDM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2014
07:04 EDTFLDMFluidigm upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Fluidigm to Outperform citing reasonable consensus revenue estimates and strong demand for single cell gene expression analysis tools. The firm has a $52 price target for shares.
April 9, 2014
08:24 EDTFLDMPiper Jaffray's medtech analysts hold an analyst/industry conference call
The MedTech Analyst Team focuses on Piper Jaffray's covered universe from the perspective of Technical Analyst Johnson ahead of 1Q14 earnings results on an Analyst/Industry conference call to be held on April 11 at 10 am.
April 7, 2014
07:44 EDTFLDMMarketo to hold a summit
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use